Cart
sales@molnova.com
Pamicogrel
CAS No. 101001-34-7
Pamicogrel( KBT3022 )
Catalog No. M22618 CAS No. 101001-34-7
Pamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 41 | In Stock |
|
| 25MG | 82 | In Stock |
|
| 50MG | 127 | In Stock |
|
| 100MG | 205 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePamicogrel
-
NoteResearch use only, not for human use.
-
Brief DescriptionPamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion.
-
DescriptionPamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. Pamicogrel also has potential in both prophylaxis and treatment of ischemic brain injury.
-
In VitroPamicogrel is a cyclooxygenase inhibitor with platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. Pamicogrel also has potential in both prophylaxis and treatment of ischemic brain injury.
-
In Vivo——
-
SynonymsKBT3022
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number101001-34-7
-
Formula Weight448.53
-
Molecular FormulaC25H24N2O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:82 mg/mL (182.82 mM; Need ultrasonic)
-
SMILESCCOC(=O)Cn1cccc1-c1nc(c(s1)-c1ccc(OC)cc1)-c1ccc(OC)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Light P. Pamicogrel (Kanebo). IDrugs. 1999 Sep;2(9):938-42.
molnova catalog
related products
-
Agnuside
Agnuside inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3 66.8 and 82.1% of P-glycoprotein (P-gp) ATPase activity at concentrations of 5 25 and 100 μM respectively.
-
Tetrahydroamentoflav...
Tetrahydroamentoflavone is a potent XO inhibitor (IC50 = 92 nM, Ki = 982 nM) with anti-inflammatory effects. Tetrahydroamentoflavone can be used for studies about inflammation and gout.
-
hCYP3A4 Fluorogenic ...
hCYP3A4 Fluorogenic substrate 1, a phthalimide derivative, exhibits low activity against COX.
